CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Abbott Laboratories is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Abbott Laboratories
100 Abbott Park Road, Abbot Park
Phone: (224) 667-6100p:224 667-6100 ABBOTT PARK, IL  60064-3500  United States Ticker: ABTABT
Business Summary
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
(Source: 10-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202412/31/2023YesYes-YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations
3845 Electromedical and electrotherapeutic apparatus
2833 Medicinal chemicals and botanical products
2835 In vitro and in vivo diagnostic substances
3841 Surgical and medical instruments and apparatus
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Robert B.Ford 50 12/10/2021 1/1/2014
Chief Financial Officer, Senior Vice President - Finance Philip P.Boudreau 51 9/1/2023 3/1/2020
Executive Vice President - Finance Robert E.Funck 62 9/1/2023 1/1/2005
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Abbott Ireland Financing DAC Ireland
ABBOTT LABORATORIES
ALERE INC.
173 additional Subsidiary records available in full report.

Business Names
Business Name
3A Nutrition (Vietnam) Company Limited
Abbott
Abbott (Jiaxing) Nutrition Co., Ltd.
614 additional Business Names available in full report.

General Information
Number of Employees: 114,000 (As of 12/31/2023)
Outstanding Shares: 1,735,184,289 (As of 2/28/2024)
Shareholders: 32,449
Stock Exchange: NYSE
Federal Tax Id: 360698440


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 20, 2024